Veyhe, S.R.; Cédile, O.; Dahlmann, S.K.; Krejcik, J.; Abildgaard, N.; Høyer, T.; Møller, M.B.; Thomassen, M.; Juul-Jensen, K.; Frederiksen, H.;
et al. Molecular Composition and Kinetics of B Cells During Ibrutinib Treatment in Patients with Chronic Lymphocytic Leukemia. Int. J. Mol. Sci. 2024, 25, 12569.
https://doi.org/10.3390/ijms252312569
AMA Style
Veyhe SR, Cédile O, Dahlmann SK, Krejcik J, Abildgaard N, Høyer T, Møller MB, Thomassen M, Juul-Jensen K, Frederiksen H,
et al. Molecular Composition and Kinetics of B Cells During Ibrutinib Treatment in Patients with Chronic Lymphocytic Leukemia. International Journal of Molecular Sciences. 2024; 25(23):12569.
https://doi.org/10.3390/ijms252312569
Chicago/Turabian Style
Veyhe, Sólja Remisdóttir, Oriane Cédile, Sara Kamuk Dahlmann, Jakub Krejcik, Niels Abildgaard, Thor Høyer, Michael Boe Møller, Mads Thomassen, Karen Juul-Jensen, Henrik Frederiksen,
and et al. 2024. "Molecular Composition and Kinetics of B Cells During Ibrutinib Treatment in Patients with Chronic Lymphocytic Leukemia" International Journal of Molecular Sciences 25, no. 23: 12569.
https://doi.org/10.3390/ijms252312569
APA Style
Veyhe, S. R., Cédile, O., Dahlmann, S. K., Krejcik, J., Abildgaard, N., Høyer, T., Møller, M. B., Thomassen, M., Juul-Jensen, K., Frederiksen, H., Dybkær, K., Hansen, M. H., & Nyvold, C. G.
(2024). Molecular Composition and Kinetics of B Cells During Ibrutinib Treatment in Patients with Chronic Lymphocytic Leukemia. International Journal of Molecular Sciences, 25(23), 12569.
https://doi.org/10.3390/ijms252312569
